Other News To Note

• Astex Pharmaceuticals Inc., of Dublin, Calif., said the FDA's Oncologic Drugs Advisory Committee will discuss its supplemental new drug application for Dacogen (decitabine) for Injection at its Feb. 9, 2012, meeting. The proposed indication for the application is elderly acute myelogenous leukemia.